| 11:30 am - 12:15 pm | Lunch Reception | |
| 12:15 pm - 4:45 pm | Sessions | |
| 12:15 pm - 12:30 pm | Welcome and Introductions Policy Forum Moderator: Ian Spatz, Senior Advisor, Manatt Health | |
| 12:30 pm - 1:00 pm | Perspectives on Prescription Drug Issues from Capitol Hill Alyssa Palisi, Professional Staff Member, House Committee on Ways and Means Rachel Pryor, Senior Health Policy Advisor, House Committee on Energy and Commerce Brett Baker, Senior Health Policy Advisor, Senate Committee on Finance (invited) | |
| 1:00 pm - 1:30 pm | Point of Sale Rebates: Opportunities in Commercial Benefits Lida Etemad, Vice President, Pharmacy Management Strategies, Employer & Individual and Community & State, UnitedHealthcare | |
| 1:30 pm - 2:00 pm | Perspectives from HHS John O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health and Human Services | |
| 2:00 pm - 2:30 pm | Outside the Beltway: State Perspectives on Prescription Drug Benefits Representative MaryLynn Magar, Florida House – District 82 (R) Representative Kevin Roberts, Texas House – District 126 (R) J.P. Wieske, Deputy Commissioner of Insurance, State of Wisconsin | |
| 2:30 pm - 3:00 pm | The Value of Specialty Pharmacy: Patient Engagement, REMS and Biosimilars Brian Seiz, Senior Vice President, Specialty, Express Scripts & President, Accredo Specialty Pharmacy | |
| 3:00 pm - 3:30 pm | How PBMs are Driving Value Based Contracting Kim Gwiazdzinski, Senior Director, Trade Relations, Value and Outcomes Contracting, Prime Therapeutics | |
| 3:30 pm - 4:00 pm | Perspectives from FDA Scott Gottlieb, Commissioner of Food and Drugs, U.S. Food & Drug Administration | |
| 4:00 pm - 4:30 pm | Employers’ Perspectives on Drug Benefit Management Kevin Host, President & Chief Operating Officer, PSG Consulting | |
| 4:30 pm - 4:45 pm | PCMA Perspectives and Wrap Up |
Thursday, April 19
